These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29109911)

  • 21. The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study.
    So KA; Hong JH; Jin HM; Kim JW; Song JY; Lee JK; Lee NW
    Gynecol Oncol; 2014 Mar; 132(3):551-5. PubMed ID: 24440470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.
    Ehlén A; Brennan DJ; Nodin B; O'Connor DP; Eberhard J; Alvarado-Kristensson M; Jeffrey IB; Manjer J; Brändstedt J; Uhlén M; Pontén F; Jirström K
    J Transl Med; 2010 Aug; 8():78. PubMed ID: 20727170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
    Kim J; Chang Y; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    J Gynecol Oncol; 2019 Jan; 30(1):e11. PubMed ID: 30479095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer.
    Hou S; Du P; Wang P; Wang C; Liu P; Liu H
    Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort.
    Pinto R; Assis J; Nogueira A; Pereira C; Coelho S; Brandão M; Dias J; Alves S; Pereira D; Medeiros R
    Pharmacogenomics J; 2019 Feb; 19(1):25-32. PubMed ID: 30287910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer.
    Lu L; Katsaros D; Mayne ST; Risch HA; Benedetto C; Canuto EM; Yu H
    Carcinogenesis; 2012 Nov; 33(11):2119-25. PubMed ID: 22822098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The down-regulation of long non-coding RNA LINC01088 is associated with the poor prognosis of epithelial ovarian cancer patients.
    Ai H; Xie W; Xiu AH; Li N; Zhang ST; Zhang YL; Xue XO
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5836-5841. PubMed ID: 30280763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer.
    Yu W; Ye Z; Fang X; Jiang X; Jiang Y
    J Ovarian Res; 2019 Sep; 12(1):88. PubMed ID: 31533857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis.
    Wang YS; Ma LN; Sun JX; Liu N; Wang H
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3169-3175. PubMed ID: 28770969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between the rs11614913 variant of miRNA-196a-2 and the risk of epithelial ovarian cancer.
    Song ZS; Wu Y; Zhao HG; Liu CX; Cai HY; Guo BZ; Xie YA; Shi HR
    Oncol Lett; 2016 Jan; 11(1):194-200. PubMed ID: 26870188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer.
    Pei ML; Zhao ZX; Shuang T
    J Ovarian Res; 2020 Dec; 13(1):144. PubMed ID: 33302997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation rs10484761 on 6p21.1 derived from a genome-wide association study is associated with gastric cancer survival in a Chinese population.
    Kang M; Ding X; Xu M; Zhu H; Liu S; Wang M; Wu D; Tong N; Gong W; Zhou J; Zhang Z
    Gene; 2014 Feb; 536(1):59-64. PubMed ID: 24325909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer.
    Qiu JJ; Guo JJ; Lv TJ; Jin HY; Ding JX; Feng WW; Zhang Y; Hua KQ
    Tumour Biol; 2013 Oct; 34(5):2971-5. PubMed ID: 23712606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.
    Tassi RA; Calza S; Ravaggi A; Bignotti E; Odicino FE; Tognon G; Donzelli C; Falchetti M; Rossi E; Todeschini P; Romani C; Bandiera E; Zanotti L; Pecorelli S; Santin AD
    BMC Cancer; 2009 Jul; 9():253. PubMed ID: 19635143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
    Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
    Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.